At the Rogel Cancer Center, there is hope, innovation and support for those diagnosed with a multiple myeloma or any other plasma cell neoplasms. Contact us:
734-647-8902
The Adult Hematology Clinic at the University of Michigan Rogel Cancer Center is comprised of faculty from the Division of Hematology/Oncology – the largest subspecialty unit within the Department of Internal Medicine.
We care for patients with myelodysplastic syndromes (MDS). Our multidisciplinary team of experts is on the leading edge of research and is committed to providing patients the very best care and treatment.
At the Rogel Cancer Center, there is hope, innovation and support for those diagnosed with a myelodysplastic syndrome. Contact us: 734-647-8902
Myelodysplastic syndromes (MDS) are diseases of the blood and bone marrow. According to the Aplastic Anemias & MDS Foundation approximately 13,000 people in the United State are diagnosed with MDS each year. It is rare to find MDS in people younger than 40, and most people who are diagnosed with MDS are over 60. It seems to occur most often in men.
Linda Thomas, former-manager of Tobacco Consultation Services for University of Michigan's M-Fit Program, explains the dangers of tobacco use -- particularly smoking -- and offers strategies for quitting. This presentation was made to cancer survivors, emphasizing the necessity of quitting tobacco use in order to prevent cancer recurrence.
Doctors cannot always explain why one person develops lung cancer and another does not. However, we do know that a person with certain risk factors may be more likely than others to develop lung cancer. A risk factor is something that may increase the chance of developing a disease.
Studies have found the following risk factors for lung cancer:
Not all cases of lung cancer can be prevented, but the best way to reduce your risk of lung cancer is not to smoke and to avoid breathing in other people's smoke.
MENU